An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity…
Study links ultra-processed food intake to poorer thigh muscle quality
A new MRI study suggests that diets high in ultra-processed foods may be linked to fattier, poorer-quality thigh…
Genetic inflammatory signature defines depression subtypes and treatment response
Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Growth Hormone Benefits Kids With Rare Genetic Condition
TOPLINE: A standard-dose recombinant growth hormone therapy administered for 2 years demonstrated positive effects on both growth and…
Most GLP-1 Prescriptions Miss the Mark: Are Yours?
GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…